JPRN-UMIN000033856招募中未知
Switching from etelcalcetide to evocalcet in hemodialysis patients with secondary hyperparathyroidism - Switching from etelcalcetide to evocalcet
Jinken Clinic0 个研究点目标入组 20 人开始时间: 2018年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Receiving hemodialysis less than three months
研究者
相似试验
已完成
4 期
Switching from cinacalcet to ebocalcet in secondary hyperparathyroidism patients during hemodialysis.Secondary hyperparathyroidismJPRN-UMIN000036862Fujita Memorial Hospita, Department of Internal Medicine20
尚未招募
不适用
The effect of switching to Eldecalcitol from Alfacalcidol on osteoporosis caused by Anastrozole / Letrozole for post-operative breast cancer.JPRN-UMIN000009182Kansai Medical University35
已完成
不适用
Efficacy of Etelcalcetide vs Cinacalcet in Hemodialyzed Patients with Secondary HyperparathyroidismSecondary HyperparathyroidismJPRN-UMIN000034155Saitama Sekishinkai Hospital50
招募中
不适用
Efficacy and safety of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism inadequately controlled with cinacalcetJPRN-UMIN000030568Jinken Clinic20
招募中
不适用
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcetPatients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidismJPRN-UMIN000028041Matsunami general hospital20